Related Experiment Videos
Pharmacologic therapy for peripheral arterial disease and claudication
1Department of Medicine, University of Colorado School of Medicine, c/o Colorado Prevention Center, 789 Sherman Street, Suite 200, Denver, CO 80203, USA. will.hiatt@uchsc.edu
Journal of Vascular Surgery
|December 7, 2002
Summary
Peripheral arterial disease (PAD) management involves aggressive risk factor control with medications like statins and antiplatelet drugs. Treatment also includes assessing limb symptoms and considering exercise or specific medications for claudication.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis.
- PAD significantly increases cardiovascular mortality risk and causes functional limitations due to limb ischemia.
Purpose of the Study:
- To outline aggressive risk factor management strategies for patients with PAD.
- To detail therapeutic approaches for limb-specific symptoms and perioperative care in PAD.
Main Methods:
- Review of evidence supporting lipid management (statins), blood pressure control (ACE inhibitors), and antiplatelet therapy (aspirin, clopidogrel).
- Assessment of limb symptom severity and consideration of structured exercise programs or pharmacotherapy (cilostazol) for claudication.
- Evaluation of antiplatelet, anticoagulant, and beta-blocker use in surgical contexts for graft patency and risk reduction.
Main Results:
- Level 1 and 2 evidence supports statins, ACE inhibitors, and antiplatelet agents for PAD risk management.
- Structured exercise or cilostazol can effectively treat claudication symptoms.
- Perioperative use of specific drug classes can improve outcomes in vascular surgery patients.
Conclusions:
- Aggressive risk factor modification is crucial for PAD patients to reduce cardiovascular events.
- Comprehensive management includes addressing limb ischemia and optimizing surgical outcomes.